Replies to post #111416 on Anavex Life Sciences Corp (AVXL)

[williamssc]

The patient population is made up of feeble geriatrics. Some probably just died from complications associated with old age and poorer health then others.

[F1ash]

Flash I did not make an assumption. It clearly says data includes all evaluable patients. A dropped patient is not evaluable, being they have dropped from the trial.

The patients didn't dropout all at once. Does the graph represent x number of patients till x date and then x number of patients from x date on?



Up until they dropped out, those patients were still "evaluable" weren't they?

Patients responding well, and patients not responding well, could have dropped out. Anavex did not control who dropped, so implying they are showing data without dropouts, you are also implying the dropouts were not responding, hence providing higher avgs and better results. Let's be real, if patients were taking 10ml doses, and they were taking 10ml doses, we would expect those patients to decline

Did I actually imply which method they were using or simply voice my frustration that it's impossible to tell without making educated guesses? I'll say, I must have misspoke if I actually implied that.

Can I ask, what's your point here?

In bold....

" The only place I see an actual number of patients is on slide 24 and that says the trial was for 32 patients. So if this graph doesn't represent 32 patients shouldn't they clearly say so?

Are they simply reluctant to say: "this is not really a 32 person trial it's a 29/27/25 (pick one) trial."